Aaron Lindeke-Myers1, Gregg T Kokame2,3,4,5,6, Steven Yeh1,7, Jessica Shantha1,7. 1. Emory University School of Medicine, Atlanta, GA. 2. Division of Ophthalmology, Department of Surgery, University of Hawaii School of Medicine, Honolulu, HI. 3. The Retina Center at Pali Momi, Aiea, HI. 4. Retina Consultants of Hawaii, Honolulu, HI. 5. Hawaii Macula and Retina Institute, Aiea, HI. 6. John A. Burns School of Medicine, University of Hawaii School of Medicine, Honolulu, HI. 7. Emory Eye Center, Department of Ophthalmology, Atlanta, GA.
Abstract
PURPOSE: To report a case of an 86-year-old man with a full thickness macular hole (FTMH) secondary to polypoidal choroidal vasculopathy (PCV) treated with bevacizumab. METHODS: A retrospective case report is presented. RESULTS: An 86-year-old male presented with a five-month history of metamorphopsia and decreased vision in his right eye and was found to have active exudation secondary to PCV with a concurrent FTMH. After four treatments with intravitreal bevacizumab, the FTMH resolved without surgical intervention. CONCLUSIONS: The patient's FTMH resolved with solely pharmacologic treatment as a result of treating his PCV with intravitreal bevacizumab. MH formation secondary to PCV is a rare finding, but may be successfully treated with pharmacologic therapy without surgical intervention.
PURPOSE: To report a case of an 86-year-old man with a full thickness macular hole (FTMH) secondary to polypoidal choroidal vasculopathy (PCV) treated with bevacizumab. METHODS: A retrospective case report is presented. RESULTS: An 86-year-old male presented with a five-month history of metamorphopsia and decreased vision in his right eye and was found to have active exudation secondary to PCV with a concurrent FTMH. After four treatments with intravitreal bevacizumab, the FTMH resolved without surgical intervention. CONCLUSIONS: The patient's FTMH resolved with solely pharmacologic treatment as a result of treating his PCV with intravitreal bevacizumab. MH formation secondary to PCV is a rare finding, but may be successfully treated with pharmacologic therapy without surgical intervention.
Authors: Chui Ming Gemmy Cheung; Timothy Y Y Lai; Paisan Ruamviboonsuk; Shih-Jen Chen; Youxin Chen; K Bailey Freund; Fomi Gomi; Adrian H Koh; Won-Ki Lee; Tien Yin Wong Journal: Ophthalmology Date: 2018-01-10 Impact factor: 12.079
Authors: Adrian Koh; Timothy Y Y Lai; Kanji Takahashi; Tien Y Wong; Lee-Jen Chen; Paisan Ruamviboonsuk; Colin S Tan; Chrystel Feller; Philippe Margaron; Tock H Lim; Won Ki Lee Journal: JAMA Ophthalmol Date: 2017-11-01 Impact factor: 7.389